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Abstract
Islets of Langerhans implantation is a viable method to treat type I diabetes. Unfortu‐
nately, during islets isolation their vascular system is disrupted, and they need external
supply  of  oxygen  and  other  nutrients.  A  photosynthetic  bioartificial  device  was
constructed to support the oxygen consumption of the islets and to treat type I diabetes.
The bioartificial device is built  in layers where the core is an illumination module
composed of a LED array and a light guide. The next layer is immobilized photosyn‐
thetic  organism  (Synechococcus  lividus).  An  oxygen-permeable  silicon/Teflon  mem‐
brane separates the photosynthetic layer from the islets of Langerhans layer. This layer
is protected from the immune system of the body by a porous Teflon membrane. The
device is  powered by batteries that supply electricity to a LED array.  The oxygen
produced by S. lividus is consumed by implanted islets of Langerhans that produce
insulin and allow the reversal of diabetes in the patient. In this chapter, we demon‐
strate the ability of S. lividus to produce oxygen after being implanted for prolonged
periods and eventually the ability of the device containing S. lividus and the islets of
Langerhans  to  reverse  diabetes  for  10  days.  To  achieve  this  task,  we  developed
improved media to grow cyanobacteria and, inter alia, developed a method to disperse
light uniformly and in very short distances.
Keywords: Bioartificial device, Cyanobacteria, Diabetes, Implanted islets of Langer‐
hans, Synechococcus lividus
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1. Introduction
Type I diabetes (T1D) is a severe disease resulting from the destruction of the beta cells in the
islets of Langerhans (islets) residing in the pancreas. The loss of beta cells leads to lack of insulin
and increased glucose levels in the blood (hyperglycemia). If untreated, T1D 1 leads to
permanent damage to small blood vessels which in turn causes blindness, kidney failure, heart
failure and eventually premature death [1,2]. Even when treated with external insulin, blood
glucose levels are not stable and fluctuate according to eating habits and insulin administra‐
tion. On the other hand, too much insulin can cause a dangerous drop in the blood glucose
level (hypoglycaemia), which leads to confusion, loss of conscience and, if not immediately
treated, sudden death.
Great efforts are made to develop a “closed loop” insulin pump that will secrete insulin when
needed (after a meal) and sense the glucose level in order to stop secretion when glucose levels
drop to normal levels. Islet implantation is another successful approach that utilizes donor's
islets isolated from the pancreas to replace the missing islets of the patient. This approach,
although promising, faces several obstacles that decrease its feasibility.
1. Harvesting of the islets from the donor pancreas is performed by enzymatic process,
completely disrupting the blood vessels to the islets. As a result, all nutrients supply and
insulin secretion from the islet rely on slow diffusion mechanism. The solubility of oxygen
in blood fluid is low and its consumption is high. Therefore, it is the first nutrient becoming
the limiting factor and it must be supplied [3].
2. Donor islets will be rejected by the immune system of the host, and therefore, constant
harmful immune suppression drugs are needed [4,5].
To approach these two fundamental problems, Beta-O2 Technologies had designed implant‐
able flat geometry device containing islets that were supplied with oxygen by immobilized
and illuminated cyanobacteria. The implanted islets are partly protected from the attack of the
immune system by a porous Teflon membrane. Photosynthesis was the source of the supply
of oxygen, which is the focus of this chapter . Indeed, the designed device termed bioartificial
pancreas contains battery-powered illumination module, photosynthetic organisms that
produce oxygen and islets that produce insulin upon demand.
To create this “science fiction” bio-artificial pancreas device, a multidisciplinary approach was
needed involving optics, material science, diffusion models, plant and islet biochemistry and
other fields.
2. The construction of the photosynthetic bioartificial pancreas
A. To construct such a complex device, several requirements had to be set:
1. The device must be as compact as possible to reduce the trauma after implantation.
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2. The batteries driving the operation of the device should last at least one month for
the proof of concept.
3. The power unit (batteries) must be separated from the bioreactor to decrease the
immune response against foreign body, which depends upon size.
4. The light distribution must be even in all the active areas to ensure uniform oxygen
production.
5. All materials exposed to body fluids must be biocompatible to provoke minimum
response of the immune system.
6. The photosynthetic organism must be functional in body temperatures and withstand
immobilization in the device and implantation conditions. It must also be spread even
so that oxygen production will be uniform, constant and in direct contact with the
islets.
7. There should be no hindrance in the diffusion of the oxygen from the oxygen
producers to the oxygen consumers — the islets.
8. The islets must be active insulin producers and must be spread and immobilized
evenly in the device to maximize diffusion quality.
9. The device must be protected from the body’s immune system.
10. The electrical parts of the device must be completely insulated from fluid penetration.
B. The selection of the photosynthetic organism
The constraints: The aim of the photosynthetic organism in this system is producing
oxygen for the islets. Body temperature is too high for most photosynthetic organisms.
The organism has to withstand temperatures between 37 and 42°C. Since the organism
has to be embedded in aqueous matrix or hydrogel, microalgae were the organism of
choice. Indeed, the first work showing the beneficial effect of photosynthetic oxygen
production on insulin secretion was conducted with the green algae Chlorella [6], but it
was an in vitro study. Very few green algae can survive and be active at 37°C, and fewer
still can withstand the much higher temperatures needed for immobilization in agarose.
Therefore, we chose to introduce thermophilic cyanobacteria. Cyanobacteria are the first
photosynthetic oxygen-evolving organisms on earth, and during the 3.5 billion years of
their existence they adapted to any environment containing light, humidity and few
minerals. Many cyanobacteria species grow at relatively low illumination, can survive
hard conditions and still grow and produce oxygen. Several members of this large group
of organisms live in proximity to geysers at temperatures reaching 70°C [7]. We chose to
use Synechococcus lividus (S. lividus), a unicellular cyanobacteria found in hot springs in
Yellowstone National Park, USA [8]. This strain was obtained from the Pasteur culture
collection (PCC6717). PCC 6717 has an optimum growth at 52–57°C but grows well also
Between 37°C and 42°C. To acclimate the S. lividus to body temperatures, it was grown
for 10 generations in liquid culture at 40°C before being taken for immobilization in the
device. Its oxygen production characteristics were checked prior to immobilization and
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were shown to be stable. In nature (Figure 1), S. lividus creates bacterial mats with other
organisms. Therefore, it is used to survive and function in the immobilized state. Occa‐
sionally, S. lividus will be termed algae for convenience, especially with relation to the
device.
Figure 1. Bacterial mat containing thermophile cyanobacteria. A slice of bacterial mat (right) from Octopus
spring (left) in Yellowstone National Park, USA. On top there is a layer of (mostly) cyanobacteria. Right panel
is a picture by Prof. David M. Ward (October 13, 2008, by Charles Fergus, Penn State News).
C. The choice of growth medium for S. lividus: How much is good enough?
The cyanobacteria are enclosed within a silicon box to be protected from the host's immune
system. All gas exchange (uptake of CO2 and secretion of O2) are performed via the silicon
membrane. Therefore, all nutrients must be supplied within the silicon box for the period
of implantation. This poses two problems:1. The osmolality of the BG-11 medium which
is the standard medium for the growth of cyanobacteria is about 40 mOsmol/l of water,
compared with 275–295 mOsmol/l of body liquid. To equilibrate the osmolalities, water
molecules as vapor will escape the algae medium, leading to drying of the algae com‐
partment. 2. BG 11 medium can support cyanobacterial growth when the medium is
changed frequently, but cannot support long-term growth or photosynthesis without
frequent changes of the medium. In the design of the bioartificial pancreas, the first
milestone was to show treatment of diabetes for a month supported by oxygen produced
by the cyanobacteria. It was difficult to obtain such a performance of the cyanobacteria
based on BG-11, so efforts were made to improve the medium in order to extend its ability
to support the photosynthetic activity of S. lividus. After several futile efforts of elevating
individual components of the medium, the overall BG-11 concentration was increased.
Surprisingly, increasing the BG-11 medium concentration 5 to 7-fold resulted in a 3-fold
increase of the S. lividus cell density (Fig. 2B). This result indicates that BG-11x5-7 is a
superior medium for the growth of S. lividus in solution, compared to BG-11. Also, since
the osmolarity was increased it resembles that of body fluids, so no water loss from the
algae compartment is anticipated. These findings enabled the use of medium that can
support a long-term oxygen production by the S. lividus under the conditions set in the
bio-artificial pancreas. It was later shown that indeed, S. lividus immobilized and im‐
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planted with BG-11x5 developed much better than S. lividus implanted in the original
BG-11, produced higher oxygen amounts and maintained its volume under immobilized
conditions.
Figure 2. Dependence of bacterial growth on BG-11 concentration. Panel A: Dependence of S. lividus culture
growth on the BG-11 concentration over time. Panel B illustrates the maximum concentration each culture
has reached. Each result is the average of at least three experiments, apart of BG-11×2 that was tried only once.
Figure 3. The oxygen measurement setup of the bioartificial pancreas. A device containing algae only (S.
lividus) immobilized in agarose plus BG-11x5 was placed in a home-made oxygen measurement cell where a
Clark-type oxygen microelectrode is inserted (Panel A). S. lividus is illuminated by a LED array as described
later. The device was kept in vitro under identical conditions to the implanted device and tested periodically
(Panel B) for oxygen production.
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As shown in Figure 3B, the oxygen production did not diminish, but actually improved
during the one month the device was tested. The BG-11 concentration in this device was
BG-11×5.
The ability of the media with elevated BG-11 concentrations to support oxygen production
in the device was shown both before and after implantation. It was shown that S. lividus
alone was able to produce oxygen that will diffuse into the islets of Langerhans compart‐
ment and will allow the islets to function properly. As can be seen in Figure 4, an oxygen
electrode is inserted into the islet part of the bioartificial pancreas. The deeper the electrode
penetrates into the islet slab and gets closer to the S. lividus chamber, the higher is the
oxygen concentration. The oxygen levels detected can support islet activity at any location
and depth of the electrode.
Figure 4. Measurement of the O2 gradient in the islet slab in the device. Panel A: Device with oxygen
electrode. Oxygen microelectrode was inserted by a micromanipulator at increments of 0.1mm into the islet
slab with a thickness of 0.6 mm. Panel B: The O2 concentration as a function of illumination and location of
the oxygen electrode. At the start of the test, the electrode tip is located at the surface of the islet slab, the
furthest point from the O2 source. The light is turned off and the oxygen is consumed (concentration drops).
The light is turned on leading to balanced O2 concentration. Under illumination the electrode is inserted into
the islet slab at 0.1mm increments, leading to a gradual increase in O2 concentration The horizontal line
indicates the O2 concetration sufficient to support the islet's O2 consumption.
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D. The illumination requirements for growth and oxygen production: the struggle for
homogeneous light
The cyanobacteria were chosen for their ability to produce oxygen even at very low light
intensities, below 1 μE/m2/s. Since the device operates on batteries, the longer the batteries
Last, the longer the device would work. The milestone was achieving normoglycemia for
one month in diabetic rats, and for that time span the batteries should hold. The light
Figure 5. Compensation between oxygen production by S. lividus and oxygen consumption by the islets. Panel
A. Schematic view of the oxygen measurement setup of the full device. Panel B. Measuring the oxygen
production rate of S. lividus (cyanobacteria) plus the islets in order to determine the light intensity required
for achieving the compensation point of the device. 1,200 islets of Langerhans, each consuming 2.5–3 pmole/
min O2, were embedded in alginate and placed on top of the S. lividus slab. Light intensity of 7μE/m2/s was
needed to reach the compensation point. The insert (600 islets) demonstrates that compensation point is
reached with light intensity (3.9μE/m2/s) which is half the light intensity needed for reaching the compensation
point with 1,200 islets.
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intensity needs to be such that it allows S. lividus to produce enough oxygen for the
consumption of the islets. Therefore, the oxygen production should be equal to the oxygen
consumption by the islets, what we termed the compensation point of the device
(Figure 5B).
Higher intensities cause excess oxygen production that can lead to oxidative stress for
both S. lividus and the implanted islets. Also, over-illumination causes loss of battery
power and early termination of the trial.
Light quality: After checking several LED types with different wavelengths, 660nm
wavelength was chosen since it is absorbed well by chlorophyll. It proved best both for
oxygen evolution and also was electrically most efficient. (E = hC/λ, where E is the energy,
h is Planck's constant, C is the speed of light and λ is the wavelength. The longer the
wavelength, the lower is the energy of the photon, and the electric energy needed for its
production.). The second, more formidable task was to disperse the light as much as
possible when it enters the S. lividus chamber. The reasons for that are: the direct result of
the illumination is oxygen production from S. lividus. We need the oxygen production to
be uniform at all parts of the algae compartment because the oxygen diffuses directly to
the islets compartment. The islets, too, need the oxygen in the most even manner, so as
not to have parts with too little oxygen that will lead to islet necrosis. On the other hand,
too high intensity will lead to oxidative stress, followed by bleaching of the cyanobacteria.
At such short distance of less than a millimetre, it is extremely hard to disperse the LED
light uniformly. Early attempts (Figure 6) show non-uniform growth of S. lividus as a result
of exposure to non-uniform light.
Figure 6. Correlation between light distribution in the device and S. lividus growth Left: The LED array on
which the immobilized S. lividus was implanted Right: an agarose slab of S. lividus implanted in a rat for 60
days on a LED array.
To achieve uniform light source we constructed a LED light guide that allows light
dispersion (patent no.) and uniform light to the S. lividus compartment (Figure 7).
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Figure 7. The bioreactor light guide Panel A. the LED operated light guide Panel B: S. lividus immobilized
in agarose slab, illuminated by the light guide. The blue colour is an artefact of the camera.
E. The immobilization of the organism: several approaches
To avoid coalescence of both organisms, the islets and the cyanobacteria have to be
separated from each other. We used hydrogels for immobilization. Two general methods
were used to immobilize the unicellular S. lividus in the device. The first one was immo‐
bilization in alginate. Alginate is a polysaccharide extracted from brown algae (kelp). It
provides flexibility and strength for the kelp to withstand the ocean currents and waves
without breaking or tearing. It is provided as a viscous liquid similar to glycerol, which
solidifies rapidly upon exposure to divalent ions, like calcium ions. We used it in the first
devices, but stopped when we started to inject the algae with its immobilizer into a closed
compartment. It was impossible to inject the alginate because of its high viscosity.
Therefore, we decided to use agarose as the immobilizer. The fact that we use thermophile
cyanobacteria helped to mix S. lividus with the liquid agarose brought to 50°C and inject
it into the device under sterile conditions. For immobilization of the islets we used alginate,
and cross-linked it with strontium.
F. The construction of the bioartificial pancreas
Physically, the best approach to supply oxygen to the islet by photosynthetic microor‐
ganisms is to mix them in the same compartment [6]. Attempts to combine the photosyn‐
thetic organisms with the islets in the same chamber and the same medium (DMED or
RPMI) resulted in the rapid death of S. lividus. Attempts to construct mini balls of S.
lividus isolated by a sol–gel coat or other protection failed as well. It was clear early on
that the S. lividus chamber and the islet chamber must be separated by a membrane that
allows the diffusion of only gases. This approach holds the risk of gas diffusion constraints
from the algae chamber to the islets chamber and vice versa. To minimize this problem,
a thin silicone/Teflon membrane is used between the algae and the islet chambers. A
second membrane that allows insulin to diffuse out and nutrients in, but blocks the
immune cells, was needed between the islets and the body.
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Several approaches were tested, but eventually we embarked with a flat device illumi‐
nating both directions having the illumination panel at the core, coated with immobilized
S. lividus and above it two islets chambers, again on both sides (Figure 8).
Figure 8. The photosynthetic bioartificial pancreas. The device has a core illumination panel directing the 660
nm light to both sides. The algae chamber is laid directly on the illumination panel and is separated from the
islet chamber with gas-permeable thin silicone/Teflon membrane. The islet chamber is protected from the
immune cells by porous biopore membrane. Panel A: Detailed cross-section of the device. Panel B: Actual
view of the device.
G. The implantation of the device: reversing diabetes in rats
As stated before, the designed device was aimed to treat type 1 diabetic (T1D) rats as
model animals. Initially, to learn the dose needed to cure STZ (Streptozotocine) diabetic
rat, we implanted various islet doses under the kidney capsule, and found that about 2400
islets are sufficient to reverse diabetes. Therefore, we constructed our device with 2400
islets. To allow implantation into non-suffering animal, it was treated with slow-release
insulin capsule (Figure 9, LPin). T1D animals were implanted with the device containing
2400 islets and the slow-release insulin capsule was removed (Figure 9, LPout). At this
stage, the only entity that can produce insulin and reverse the diabetes is the implanted
device (Figure 9).
This experiment, which is the culmination of efforts ranging from physics, optics, material
engineering, islet biology and microbial photosynthesis, is a remarkable multidisciplinary
project ending in success, although only partial.
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Figure 9. The effect of bioartificial pancreas implantation on the glycemic state of the implanted diabetic rat.
The implanted device, driven by light and supplies oxygen by photosynthesis, allowed the implanted islets
to function well and produce enough insulin to reverse diabetes in rats for 10 days (day 0 to day 9).
H. Conclusions and further possibilities
Several issues should be addressed when planning to continue toward a working device
to treat lab animals and later, humans, with the bioartificial photosynthetic device.
1. The device can probably be active in the body for few months. However, the im‐
planted batteries which power the light need to be recharged. Therefore, a recharging
mechanism is needed.
2. Most of the oxygen is produced from photosynthesis during the logarithmic phase.
The growth leads to self-shading that increasingly leads to light limitation. Overall
produced oxygen will then eventually decrease. Example of that can be seen in
Figure 6, where above the LEDs, S. lividus is much darker than the surroundings. A
possible solution is developing a method of removing the excess cyanobacteria (see
next paragraph).
3. Although great advances were made in improving S. lividus growth medium,
eventually it will be exhausted, leading to a culture in the stationary phase and lack
of oxygen production. A method must be found to exchange the medium periodi‐
cally.
4. Scaling up the device to human size will require more islets packed at a higher
density. To compensate for the increased islet density, more O2 has to be produced.
However, using this type of solid-state bioreactor, we reached the maximum O2
production rate. Therefore, in order to supply O2 to bioartificial pancreas with
dimensions that are practical for implantation in human, the photosynthesis ap‐
proach should be greatly improved.
To summarize, we showed the ability to combine cells of two organisms, one that produce
O2 and the other that consume it, into one implantable device, achieving normoglycemia in
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T1D rat. In addition, we developed the effective means to disperse light in water and at very
short distances.
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